(Press-News.org) PHILADELPHIA — For nearly 50 years, the American Heart Association, with the help of researchers and physicians from across the nation, has developed and disseminated guidelines on how best to perform cardiopulmonary resuscitation on patients experiencing cardiac arrest. But no such evidence-based guidelines existed in the veterinary world. Perhaps as a result, while more than 20 percent of human patients who suffer cardiac arrests in the hospital survive to go home to their families, the equivalent figure for dogs and cats is less than 6 percent.
Now the Reassessment Campaign on Veterinary Resuscitation, or RECOVER, a collaborative effort of the American College of Veterinary Emergency and Critical Care and the Veterinary Emergency and Critical Care Society, has arrived at the first evidence-based recommendations to resuscitate dogs and cats in cardiac arrest.
The RECOVER initiative was spearheaded by Manuel Boller, a senior research investigator in the University of Pennsylvania School of Veterinary Medicine and the Center for Resuscitation Science of Penn's Perelman School of Medicine, and Daniel J. Fletcher, an assistant professor in veterinary emergency and critical care at Cornell University's College of Veterinary Medicine. RECOVER aims to standardize treatment of cardiac arrest in pets, ultimately leading to improved outcomes.
In a special issue of the Journal of Veterinary Emergency and Critical Care published today, a series of articles outlines the new guidelines as well as the method by which they were identified. The articles also include algorithms and drug-dose charts for practitioners to follow.
The need for pet-CPR guidelines became obvious when Boller and colleagues surveyed veterinarians on how they treated dogs and cats in cardiac arrest. The results, compiled from more than 600 practitioners, showed a large amount of variation.
"What we found was that there was really no consensus on how to do that best," Boller said. "There may have been a cohort, for example, that recommended 60-80 compressions per minute and another that thought 120-150 compressions per minute was the right thing."
Boller and Fletcher recruited more than 100 board-certified veterinary specialists from around the world who systematically reviewed more than 1,000 scientific papers related to CPR. Weighting the studies by their rigor and relevance to dogs and cats, the committee ended up with 101 specific clinical guidelines. Each has a rating based on the strength of the evidence backing it.
Among the recommended practices:
Perform 100-120 chest compressions per minute of one-third to one-half of the chest width, with the animal lying on its side.
Ventilate intubated dogs and cats at a rate of 10 breaths per minute, or at a compression to ventilation ratio of 30 to 2 for mouth-to-snout ventilation.
Perform CPR in 2-minute cycles, switching the "compressor" each cycle.
Administer vasopressors every 3 minutes during CPR.
Other guidelines pertain to how clinicians should be trained, how to perform CPR on dogs of different breeds and sizes, what drugs to give when and what follow-up care to provide.
"We identified two overarching goals for our research: first to devise clinical guidelines establishing how to best treat cardiopulmonary arrest in dogs and cats, and second to identify important knowledge gaps in veterinary CPR that need to be filled in order to improve the quality of recommendations, and thus the quality of patient care in the future," said Fletcher. "With this knowledge we can construct and implement educational initiatives that are evidence-based."
The RECOVER guidelines represent a unique partnership between veterinary experts and physician-scientists who study and treat cardiac arrest in humans. The initiative exemplifies an effort to provide the same evidence-based care for family pets that physicians employ to save human victims of cardiac arrest, which remains one of the nation's leading killers.
"When you look at guidelines for human CPR, they have been heavily informed by research done with animals, which forms the fundamental concepts to build clinical trials on," said Boller, who works closely with leaders of Penn Medicine's Center for Resuscitation Science to develop new techniques for cardiac arrest treatment. "Now, what we're doing is turning things around by using the clinical research that was conducted in humans to inform how we should do CPR to help our animals. It's really getting something back from this process of helping humans."
By identifying the gaps in knowledge of how to best perform CPR, Boller said, RECOVER should inspire new research.
"Ultimately I hope RECOVER will lead to novel interventions and really move the field forward," he said.
Using the new guidelines, the RECOVER team is developing an Internet-based training curriculum to certify clinicians in veterinary CPR. This certification is being peer-reviewed by the American College of Veterinary Emergency and Critical Care, much as the training materials for human CPR are accredited by the American Heart Association. The guidelines will be updated regularly, with the next RECOVER planned for 2017.
INFORMATION: END
Berlin, Germany, June 8 2012: Data from a Phase IIb study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, show that 76% of patients with active rheumatoid arthritis (RA) receiving either 4mg or 8mg of baricitinib, an oral JAK1/JAK2 inhibitor, plus stable methotrexate (MTX) achieved ACR20* response compared with 41% of placebo-treated patients (p≤0.001) at 12 weeks. The 4mg and 8mg doses of baricitinib demonstrated statistical superiority to placebo in all clinical outcomes measured, including ACR20/50/70*, DAS28**-CRP ...
June 8, 2012 — (Bronx, NY) — Patients vary widely in their response to concussion, but scientists haven't understood why. Now, using a new technique for analyzing data from brain imaging studies, researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that concussion victims have unique spatial patterns of brain abnormalities that change over time.
The new technique could eventually help in assessing concussion patients, predicting which head injuries are likely to have long-lasting neurological consequences, ...
Berlin, Germany, June 8 2012: A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, reinforces current thinking that smoking negatively affects treatment response in rheumatoid arthritis (RA) patients treated with anti-tumour necrosis factor (anti-TNF) drugs.
This American study, the largest of its kind, followed 2,811 treatment naïve patients initiated onto anti-TNF therapy. Of the study group, 19% (n=521) were smokers and 81% (n=2,290) were non-smokers. Smokers had significantly higher scores on the Clinical Disease ...
Berlin, Germany, June 8 2012: A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that lung changes in association with anti-citrullinated protein autoantibody (ACPA) status are a primary manifestation of rheumatoid arthritis (RA).
Study findings show that 51% of RA patients (n=105) had identifiable lung changes (as measured by high resolution computer tomography [HRCT]) as compared to 28% of healthy controls (n=43). In addition, ACPA presence – but not smoking status – was associated with HRCT changes. This ...
Berlin, Germany, June 8 2012: According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with psoriatic arthritis (PsA) who are starting anti-tumour necrosis factor (anti-TNF) treatment and adhere to a hypocaloric diet have a significantly greater chance of achieving minimal disease activity (MDA, an important measure of disease activity) at six months compared to those on a standard diet.
The results of an Italian study of 138 obese PsA patients demonstrated that those who achieved a ≥10% weight ...
Berlin, Germany, June 8 2012: A new Phase III study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that patients with active psoriatic arthritis (PsA) treated with Ustekinumab (UST) 90mg were more than twice as likely to achieve the study's primary endpoint, ACR20* at 24 weeks, than those treated with placebo (49.5% vs 22.8%). 42.4% of patients treated with UST 45mg were also more likely to achieve ACR20 at 24 weeks compared to placebo.
Significant improvements were also seen with UST 45mg and 90mg in ACR50* (24.9% ...
Berlin, Germany, June 8 2012 : A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that early menopause predicts a milder form of rheumatoid arthritis (RA). New insights on factors influencing RA are good news for sufferers of the chronic inflammatory disease that currently affects over 2 million women in Europe. 1,2
The study, based on 134 incident RA cases, found that patients aged over 45 years with a history of early menopause were 50% less likely to develop severe RA (16% versus 35%) and more likely to develop ...
Berlin, Germany, June 8 2012: Results of a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, suggest that the newly developed RABBIT Risk Score, which calculates the risk of serious infections in patients with rheumatoid arthritis (RA) who are treated with anti-tumour necrosis factor drugs (anti-TNFs) or conventional disease modifying anti-rheumatic drugs (DMARDs) is a valid and effective tool for rheumatologists to predict risk of serious infection.
The German study used data from 2,603 patients enrolled in the RABBIT ...
June 8, 2012, New York, NY—In 2011, 13.7 million young adults ages 19 to 25 stayed on or joined their parents' health plans, including 6.6 million who would likely not have been able to do so before passage of the Affordable Care Act, according to a new Commonwealth Fund report.
However, not all young adults have parents with health plans they can join, and many still experience gaps in coverage and face medical bill problems and medical debt. Nearly two of five (39%) young adults ages 19 to 29 went without health insurance at some time in 2011, and more than one-third ...
Small firms feeling the squeeze following the Royal Mail's decision to increase the price of first and second class stamps at the end of last month are being offered a helping hand by Bolton-based online parcel delivery firm Parcel2Go.
The company says businesses and individuals can try to beat the Royal Mail price increase by becoming Parcel2Go users and benefiting from the vast range of reliable and cost-effective UK express delivery solutions available through the website.
With just a few clicks of a mouse, customers can order delivery services from some of the ...